Sign inGet started

Lee Frank D.

Insider CIK 1814686 · PCRX Chief Executive Officer, Director · FMTX President and CEO, Director · BOLT Director · BHC Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BHC Bausch Health Companies In A Award2026-05-222026-05-2645,871— $095,210SEC↗
BHC Bausch Health Companies In S Sale2026-05-192026-05-2024,456$5.43 $132.8K49,339SEC↗
PCRX Pacira BioSciences, Inc. A Award2026-02-112026-02-13261,818— $0660,831SEC↗
PCRX Pacira BioSciences, Inc. F Tax w/h2026-01-302026-02-0341,488$20.54 $852.2K399,013SEC↗
PCRX Pacira BioSciences, Inc. F Tax w/h2026-01-022026-01-069,272$24.46 $226.8K440,501SEC↗
BHC Bausch Health Companies In S Sale2025-08-212025-08-2215,912$7.66 $121.9K73,795SEC↗
BHC Bausch Health Companies In A Award2025-05-162025-05-2054,347— $089,707SEC↗
PCRX Pacira BioSciences, Inc. A Award2025-02-012025-02-04350,000— $0448,409SEC↗
PCRX Pacira BioSciences, Inc. F Tax w/h2025-01-022025-01-069,375$18.33 $171.8K98,409SEC↗
PCRX Pacira BioSciences, Inc. P Buy2024-08-122024-08-138,264$12.10 $100.0K107,784SEC↗
BOLT Bolt Biotherapeutics, Inc. A Award deriv2024-06-122024-06-1422,000— $022,000SEC↗
BHC Bausch Health Companies In A Award2024-05-172024-05-2135,360— $035,360SEC↗
PCRX Pacira BioSciences, Inc. A Award deriv2024-01-032024-01-04692,512— $0692,512SEC↗
PCRX Pacira BioSciences, Inc. A Award2024-01-022024-01-0499,520— $099,520SEC↗
BOLT Bolt Biotherapeutics, Inc. A Award deriv2023-06-122023-06-1425,000— $025,000SEC↗
FMTX Forma Therapeutics Holding D To issuer deriv2022-10-142022-10-14182,500— $00SEC↗
FMTX Forma Therapeutics Holding D To issuer deriv2022-10-142022-10-14678,357— $00SEC↗
FMTX Forma Therapeutics Holding D To issuer deriv2022-10-142022-10-1470,134— $00SEC↗
FMTX Forma Therapeutics Holding D To issuer deriv2022-10-142022-10-14748,100— $00SEC↗
FMTX Forma Therapeutics Holding D To issuer deriv2022-10-142022-10-1471,770— $00SEC↗
FMTX Forma Therapeutics Holding D To issuer deriv2022-10-142022-10-14175,875— $00SEC↗
FMTX Forma Therapeutics Holding U Tender2022-10-142022-10-14201,436— $00SEC↗
BOLT Bolt Biotherapeutics, Inc. A Award deriv2022-06-102022-06-1025,000— $025,000SEC↗
BOLT Bolt Biotherapeutics, Inc. A Award deriv2022-03-242022-03-2822,140— $022,140SEC↗
BOLT Bolt Biotherapeutics, Inc. A Award deriv2022-03-242022-03-2814,071— $014,071SEC↗
FMTX Forma Therapeutics Holding A Award deriv2022-02-282022-03-02182,500— $0182,500SEC↗
FMTX Forma Therapeutics Holding A Award2022-02-282022-03-02121,667— $0201,436SEC↗
FMTX Forma Therapeutics Holding S Sale2022-02-232022-02-2517,981$9.78 $175.9K79,769SEC↗
BOLT Bolt Biotherapeutics, Inc. A Award deriv2021-11-172021-11-1927,860— $027,860SEC↗
FMTX Forma Therapeutics Holding A Award deriv2021-02-262021-03-02175,875— $0175,875SEC↗
FMTX Forma Therapeutics Holding A Award2021-02-262021-03-0257,750— $057,750SEC↗
FMTX Forma Therapeutics Holding A Award2021-02-262021-03-0240,000— $097,750SEC↗
FMTX Forma Therapeutics Holding A Award deriv2020-06-182020-06-2271,770— $00SEC↗